Rise was always going to happen. Covid is sexy. It’s a question of whether we can keep up momentum with progression of our own product.
I suspect we will get less than satisfactory clinical results because of sample contamination, but enough to progress to market. Then we have to find someone willing to buy from us on a competitive field.
We need better test results to stand out from the crowd - or success with saliva. Either of those two gives us a much better shot.
No idea whether SP momentum continues tomorrow or opportunists dump. Here’s hoping for the former.
ADO Charting and Technical Analysis, page-77
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $50.57M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $38.09K | 1.731M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1505316 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 676543 | 1 |
View Market Depth
| Last trade - 15.57pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.2¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.3¢ | 2.2¢ | 764931 | ||
| Last updated 15.55pm 03/05/2024 ? | |||||
| ADO (ASX) Chart |